Loading…
Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo
We found that strawberry extract suppressed immunoglobulin (Ig) E production in vitro and in vivo, and identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as one of the IgE suppressor in the extract. We report here the effect of GAPDH on various Ig productions in vitro and in vivo. GAPDH sup...
Saved in:
Published in: | Cytotechnology (Dordrecht) 2021-06, Vol.73 (3), p.333-342 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913 |
---|---|
cites | cdi_FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913 |
container_end_page | 342 |
container_issue | 3 |
container_start_page | 333 |
container_title | Cytotechnology (Dordrecht) |
container_volume | 73 |
creator | Iwamoto, Akira Inoue, Yuichi Tachibana, Hirofumi Kawahara, Hiroharu |
description | We found that strawberry extract suppressed immunoglobulin (Ig) E production in vitro and in vivo, and identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as one of the IgE suppressor in the extract. We report here the effect of GAPDH on various Ig productions in vitro and in vivo. GAPDH suppressed IgE and enhanced IgA, IgG and IgM productions in ovalbumin (OVA)-stimulated human peripheral blood mononuclear cells. Oral administration of GAPDH at 10 mg/kg/day to OVA-induced allergy model mice tended to decrease total IgE level and increase total IgA and IgG levels in sera, and also decreased OVA-specific IgE and IgG levels. It is known that the increase of total IgA as well as the decrease of total and specific IgE is important for alleviating allergic symptoms. In addition, GAPDH accelerated IgA production and increased some cytokine secretions such as IL-4, TGF-β1 and IFN-γ in the OVA-immunized mice spleen lymphocytes. These cytokines involved in the class-switching, IgA enhancement, and IgE suppression, respectively, supporting above results. Our study suggests a possibility that oral administration of GAPDH may induce the immunomodulation in allergic responses. |
doi_str_mv | 10.1007/s10616-020-00438-z |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8166990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2535302074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EosO0L8AqEpuyCFz_JfYGqSrQVqrULmBteeKbTKrEHuxkqunT4zYVCBZdWb73O8c-OoS8p_CJAtSfE4WKViUwKAEEV-XDK7KisuYl1LV6TVag80pDpY_Iu5TuAEDXlL8lR1xQoWmlV-T-ahxnH8bg5sFOIR4KbFtspiK0RTccGox2cLg9OCx5uduGtNvaCYunUQwdepuwOL04u_16-bHofWGHAWPXN0UTvOunPvj0ON73UwyF9W657MMxedPaIeHJ87kmP79_-3F-WV7fXFydn12XjaTVVG6UdU42limsWcucctZVshZ8Q6tKVQIpUskcMsyRoQV0nEkKqAXlrdKUr8mXxXc3b0Z0DfopJzK72I82Hkywvfl34_ut6cLeqPyA1pANTp8NYvg1Y5rM2KcGh8F6DHMyTApegxSgMvrhP_QuzNHneIZpqlgthGQvUpJLnuvM-daELVQTQ0oR2z9fpmAe2zdL-ybj5ql985BFfBGlDPsO41_rF1S_AS0xshk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918274452</pqid></control><display><type>article</type><title>Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Iwamoto, Akira ; Inoue, Yuichi ; Tachibana, Hirofumi ; Kawahara, Hiroharu</creator><creatorcontrib>Iwamoto, Akira ; Inoue, Yuichi ; Tachibana, Hirofumi ; Kawahara, Hiroharu</creatorcontrib><description>We found that strawberry extract suppressed immunoglobulin (Ig) E production in vitro and in vivo, and identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as one of the IgE suppressor in the extract. We report here the effect of GAPDH on various Ig productions in vitro and in vivo. GAPDH suppressed IgE and enhanced IgA, IgG and IgM productions in ovalbumin (OVA)-stimulated human peripheral blood mononuclear cells. Oral administration of GAPDH at 10 mg/kg/day to OVA-induced allergy model mice tended to decrease total IgE level and increase total IgA and IgG levels in sera, and also decreased OVA-specific IgE and IgG levels. It is known that the increase of total IgA as well as the decrease of total and specific IgE is important for alleviating allergic symptoms. In addition, GAPDH accelerated IgA production and increased some cytokine secretions such as IL-4, TGF-β1 and IFN-γ in the OVA-immunized mice spleen lymphocytes. These cytokines involved in the class-switching, IgA enhancement, and IgE suppression, respectively, supporting above results. Our study suggests a possibility that oral administration of GAPDH may induce the immunomodulation in allergic responses.</description><identifier>ISSN: 0920-9069</identifier><identifier>EISSN: 1573-0778</identifier><identifier>DOI: 10.1007/s10616-020-00438-z</identifier><identifier>PMID: 34149169</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Allergies ; Aluminum ; Animal models ; Biochemistry ; Biomedicine ; Biotechnology ; Cancer ; Chemistry ; Chemistry and Materials Science ; Cytokines ; Dehydrogenases ; Dermatitis ; Enzymes ; Food allergies ; Functional foods & nutraceuticals ; Glyceraldehyde-3-phosphate dehydrogenase ; Immunoglobulin A ; Immunoglobulin E ; Immunoglobulin G ; Immunoglobulin M ; Immunomodulation ; Interleukin 4 ; Leukocytes (mononuclear) ; Lymphocytes ; Oral administration ; Original Research ; Ovalbumin ; Peripheral blood mononuclear cells ; Secretions ; Spleen ; Transforming growth factor-b1 ; γ-Interferon</subject><ispartof>Cytotechnology (Dordrecht), 2021-06, Vol.73 (3), p.333-342</ispartof><rights>Springer Nature B.V. 2020</rights><rights>Springer Nature B.V. 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913</citedby><cites>FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166990/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166990/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Iwamoto, Akira</creatorcontrib><creatorcontrib>Inoue, Yuichi</creatorcontrib><creatorcontrib>Tachibana, Hirofumi</creatorcontrib><creatorcontrib>Kawahara, Hiroharu</creatorcontrib><title>Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo</title><title>Cytotechnology (Dordrecht)</title><addtitle>Cytotechnology</addtitle><description>We found that strawberry extract suppressed immunoglobulin (Ig) E production in vitro and in vivo, and identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as one of the IgE suppressor in the extract. We report here the effect of GAPDH on various Ig productions in vitro and in vivo. GAPDH suppressed IgE and enhanced IgA, IgG and IgM productions in ovalbumin (OVA)-stimulated human peripheral blood mononuclear cells. Oral administration of GAPDH at 10 mg/kg/day to OVA-induced allergy model mice tended to decrease total IgE level and increase total IgA and IgG levels in sera, and also decreased OVA-specific IgE and IgG levels. It is known that the increase of total IgA as well as the decrease of total and specific IgE is important for alleviating allergic symptoms. In addition, GAPDH accelerated IgA production and increased some cytokine secretions such as IL-4, TGF-β1 and IFN-γ in the OVA-immunized mice spleen lymphocytes. These cytokines involved in the class-switching, IgA enhancement, and IgE suppression, respectively, supporting above results. Our study suggests a possibility that oral administration of GAPDH may induce the immunomodulation in allergic responses.</description><subject>Allergies</subject><subject>Aluminum</subject><subject>Animal models</subject><subject>Biochemistry</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Cytokines</subject><subject>Dehydrogenases</subject><subject>Dermatitis</subject><subject>Enzymes</subject><subject>Food allergies</subject><subject>Functional foods & nutraceuticals</subject><subject>Glyceraldehyde-3-phosphate dehydrogenase</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin E</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin M</subject><subject>Immunomodulation</subject><subject>Interleukin 4</subject><subject>Leukocytes (mononuclear)</subject><subject>Lymphocytes</subject><subject>Oral administration</subject><subject>Original Research</subject><subject>Ovalbumin</subject><subject>Peripheral blood mononuclear cells</subject><subject>Secretions</subject><subject>Spleen</subject><subject>Transforming growth factor-b1</subject><subject>γ-Interferon</subject><issn>0920-9069</issn><issn>1573-0778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EosO0L8AqEpuyCFz_JfYGqSrQVqrULmBteeKbTKrEHuxkqunT4zYVCBZdWb73O8c-OoS8p_CJAtSfE4WKViUwKAEEV-XDK7KisuYl1LV6TVag80pDpY_Iu5TuAEDXlL8lR1xQoWmlV-T-ahxnH8bg5sFOIR4KbFtspiK0RTccGox2cLg9OCx5uduGtNvaCYunUQwdepuwOL04u_16-bHofWGHAWPXN0UTvOunPvj0ON73UwyF9W657MMxedPaIeHJ87kmP79_-3F-WV7fXFydn12XjaTVVG6UdU42limsWcucctZVshZ8Q6tKVQIpUskcMsyRoQV0nEkKqAXlrdKUr8mXxXc3b0Z0DfopJzK72I82Hkywvfl34_ut6cLeqPyA1pANTp8NYvg1Y5rM2KcGh8F6DHMyTApegxSgMvrhP_QuzNHneIZpqlgthGQvUpJLnuvM-daELVQTQ0oR2z9fpmAe2zdL-ybj5ql985BFfBGlDPsO41_rF1S_AS0xshk</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Iwamoto, Akira</creator><creator>Inoue, Yuichi</creator><creator>Tachibana, Hirofumi</creator><creator>Kawahara, Hiroharu</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210601</creationdate><title>Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo</title><author>Iwamoto, Akira ; Inoue, Yuichi ; Tachibana, Hirofumi ; Kawahara, Hiroharu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Allergies</topic><topic>Aluminum</topic><topic>Animal models</topic><topic>Biochemistry</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Cytokines</topic><topic>Dehydrogenases</topic><topic>Dermatitis</topic><topic>Enzymes</topic><topic>Food allergies</topic><topic>Functional foods & nutraceuticals</topic><topic>Glyceraldehyde-3-phosphate dehydrogenase</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin E</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin M</topic><topic>Immunomodulation</topic><topic>Interleukin 4</topic><topic>Leukocytes (mononuclear)</topic><topic>Lymphocytes</topic><topic>Oral administration</topic><topic>Original Research</topic><topic>Ovalbumin</topic><topic>Peripheral blood mononuclear cells</topic><topic>Secretions</topic><topic>Spleen</topic><topic>Transforming growth factor-b1</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwamoto, Akira</creatorcontrib><creatorcontrib>Inoue, Yuichi</creatorcontrib><creatorcontrib>Tachibana, Hirofumi</creatorcontrib><creatorcontrib>Kawahara, Hiroharu</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cytotechnology (Dordrecht)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwamoto, Akira</au><au>Inoue, Yuichi</au><au>Tachibana, Hirofumi</au><au>Kawahara, Hiroharu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo</atitle><jtitle>Cytotechnology (Dordrecht)</jtitle><stitle>Cytotechnology</stitle><date>2021-06-01</date><risdate>2021</risdate><volume>73</volume><issue>3</issue><spage>333</spage><epage>342</epage><pages>333-342</pages><issn>0920-9069</issn><eissn>1573-0778</eissn><abstract>We found that strawberry extract suppressed immunoglobulin (Ig) E production in vitro and in vivo, and identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as one of the IgE suppressor in the extract. We report here the effect of GAPDH on various Ig productions in vitro and in vivo. GAPDH suppressed IgE and enhanced IgA, IgG and IgM productions in ovalbumin (OVA)-stimulated human peripheral blood mononuclear cells. Oral administration of GAPDH at 10 mg/kg/day to OVA-induced allergy model mice tended to decrease total IgE level and increase total IgA and IgG levels in sera, and also decreased OVA-specific IgE and IgG levels. It is known that the increase of total IgA as well as the decrease of total and specific IgE is important for alleviating allergic symptoms. In addition, GAPDH accelerated IgA production and increased some cytokine secretions such as IL-4, TGF-β1 and IFN-γ in the OVA-immunized mice spleen lymphocytes. These cytokines involved in the class-switching, IgA enhancement, and IgE suppression, respectively, supporting above results. Our study suggests a possibility that oral administration of GAPDH may induce the immunomodulation in allergic responses.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>34149169</pmid><doi>10.1007/s10616-020-00438-z</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0920-9069 |
ispartof | Cytotechnology (Dordrecht), 2021-06, Vol.73 (3), p.333-342 |
issn | 0920-9069 1573-0778 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8166990 |
source | Open Access: PubMed Central; Springer Nature |
subjects | Allergies Aluminum Animal models Biochemistry Biomedicine Biotechnology Cancer Chemistry Chemistry and Materials Science Cytokines Dehydrogenases Dermatitis Enzymes Food allergies Functional foods & nutraceuticals Glyceraldehyde-3-phosphate dehydrogenase Immunoglobulin A Immunoglobulin E Immunoglobulin G Immunoglobulin M Immunomodulation Interleukin 4 Leukocytes (mononuclear) Lymphocytes Oral administration Original Research Ovalbumin Peripheral blood mononuclear cells Secretions Spleen Transforming growth factor-b1 γ-Interferon |
title | Immunomodulatory effect of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in allergic conditions in vitro and in vivo |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A43%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunomodulatory%20effect%20of%20glyceraldehyde-3-phosphate%20dehydrogenase%20(GAPDH)%20in%20allergic%20conditions%20in%20vitro%20and%20in%20vivo&rft.jtitle=Cytotechnology%20(Dordrecht)&rft.au=Iwamoto,%20Akira&rft.date=2021-06-01&rft.volume=73&rft.issue=3&rft.spage=333&rft.epage=342&rft.pages=333-342&rft.issn=0920-9069&rft.eissn=1573-0778&rft_id=info:doi/10.1007/s10616-020-00438-z&rft_dat=%3Cproquest_pubme%3E2535302074%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c516t-b8add5ca28e72f2d8dad65743b166864e1e152de2e0770f0ed32510e9413f8913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2918274452&rft_id=info:pmid/34149169&rfr_iscdi=true |